Detalhe da pesquisa
1.
Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment.
Int J Mol Sci
; 23(14)2022 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35887247